NCT07129187
- Conditions
- Breast Diseases, Breast Neoplasms, Early Breast Cancer, +7 more
- Locations
-
Not specified
Clinical trial condition
Stage III Breast Cancer
Explore clinical trials studying Stage III Breast Cancer. Study availability and eligibility vary by location and protocol.
36 public trials
9 recruiting studies
Stage III Breast Cancer trial results
Active, not recruiting
Niraparib + Dostarlimab In BRCA Mutated Breast Cancer
NCT04584255
- Conditions
- Breast Cancer, Breast Diseases, Breast Neoplasms, +11 more
- Locations
-
- Yale University Cancer Center New Haven, Connecticut, United States
- Johns Hopkins University Baltimore, Maryland, United States
- Massachusetts General Hospital Boston, Massachusetts, United States
- Beth Israel Deaconess Medical Center Boston, Massachusetts, United States
Active, not recruiting
Improving Exercise Capacity With a Tailored Physical Activity Intervention
NCT05595577
- Conditions
- Breast Diseases, Breast Neoplasms, Heart; Functional Disturbance, +19 more
- Locations
-
- Wake Forest Baptist Comprehensive Cancer Center Winston-Salem, North Carolina, United States
- Virginia Commonwealth University Richmond, Virginia, United States
Active, not recruiting
Acupuncture Pilot Study for Cancer-related Cognitive Function
NCT04007770
- Conditions
- Breast Diseases, Breast Neoplasms, Colonic Diseases, +33 more
- Locations
-
- Memorial Sloan Kettering Basking Ridge Basking Ridge, New Jersey, United States
- Memorial Sloan Kettering Monmouth Middletown, New Jersey, United States
- Memorial Sloan Kettering Bergen Montvale, New Jersey, United States
- Memorial Sloan Kettering Commack Commack, New York, United States
Active, not recruiting
Platinum in Treating Patients With Residual Triple-Negative Breast Cancer Following Neoadjuvant Chemotherapy
NCT02445391
- Conditions
- Breast Diseases, Breast Neoplasms, Estrogen Receptor Negative, +16 more
- Locations
-
- Mobile Infirmary Medical Center Mobile, Alabama, United States
- University of South Alabama Mitchell Cancer Institute Mobile, Alabama, United States
- Anchorage Associates in Radiation Medicine Anchorage, Alaska, United States
- Anchorage Radiation Therapy Center Anchorage, Alaska, United States
Active, not recruiting
Avelumab With Binimetinib, Sacituzumab Govitecan, or Liposomal Doxorubicin in Treating Stage IV or Unresectable, Recurrent Triple Negative Breast Cancer
NCT03971409
- Conditions
- Breast Diseases, Breast Neoplasms, Invasive Breast Carcinoma, +13 more
- Locations
-
- O'Neal Comprehensive Cancer Center Birmingham, Alabama, United States
- University of California, San Francisco San Francisco, California, United States
- Georgetown University Washington D.C., District of Columbia, United States
- University of Chicago Medicine Comprehensive Cancer Center Evergreen Park, Illinois, United States
Active, not recruiting
T-DM1+Pertuzumab in Pre-OP Early-Stage HER2+ BRCA
NCT02326974
- Conditions
- Breast Cancer, Breast Diseases, Breast Neoplasms, +7 more
- Locations
-
- Massachusetts General Hospital Boston, Massachusetts, United States
- Dana Farber Cancer Institute Boston, Massachusetts, United States
- Tennessee Oncology/Sarah Cannon Research Institute Nashville, Tennessee, United States
- Vanderbilt-Ingram Cancer Center Nashville, Tennessee, United States
Active, not recruiting
Vaccine Therapy in Treating Patients With HER2-Negative Stage III-IV Breast Cancer
NCT02157051
- Conditions
- Breast Diseases, Breast Neoplasms, HER2 Negative Breast Carcinoma, +10 more
- Locations
-
- Fred Hutch/University of Washington Cancer Consortium Seattle, Washington, United States
Active, not recruiting
MARGetuximab Or Trastuzumab (MARGOT)
NCT04425018
- Conditions
- Breast Cancer, Breast Diseases, Breast Neoplasms, +7 more
- Locations
-
- Georgetown University Medical Center Washington D.C., District of Columbia, United States
- MedStar Washington Hospital Center Washington D.C., District of Columbia, United States
- Beth Israel Deaconess Medical Center Boston, Massachusetts, United States
- Dana Farber Cancer Institute Boston, Massachusetts, United States
NCT02860000
- Conditions
- Breast Diseases, Breast Neoplasms, Estrogen Receptor Status, +12 more
- Locations
-
- Georgetown University Medical Center Washington D.C., District of Columbia, United States
- Dana-Farber Cancer Institute Boston, Massachusetts, United States
- University of Michigan Ann Arbor, Michigan, United States
- Mayo Clinic Rochester, Minnesota, United States